Literature DB >> 26972086

Treatment of breast cancer with simultaneous integrated boost in hybrid plan technique : Influence of flattening filter-free beams.

Marzieh Bahrainy1, Matthias Kretschmer2, Vincent Jöst2, Astrid Kasch2, Florian Würschmidt2, Jörg Dahle2, Jörn Lorenzen2.   

Abstract

OBJECTIVE: The present study compares in silico treatment plans using hybrid plan technique during hypofractionated radiation of mammary carcinoma with simultaneous integrated boost (SIB). The influence of 6 MV photon radiation in flattening filter free (FFF) mode against the clinical standard flattening filter (FF) mode is to be examined. PATIENTS AND METHODS: RT planning took place with FF and FFF radiation plans for 10 left-sided breast cancer patients. Hybrid plans were realised with two tangential IMRT fields and one VMAT field. The dose prescription was in line with the guidelines in the ARO-2010-01 study. The dosimetric verification took place with a manufacturer-independent measurement system.
RESULTS: Required dose prescriptions for the planning target volumes (PTV) were achieved for both groups. The average dose values of the ipsi- and contralateral lung and the heart did not differ significantly. The overall average incidental dose to the left anterior descending artery (LAD) of 8.24 ± 3.9 Gy in the FFF group and 9.05 ± 3.7 Gy in the FF group (p < 0.05) were found. The dosimetric verifications corresponded to the clinical requirements. FFF-based RT plans reduced the average treatment time by 17 s/fraction.
CONCLUSION: In comparison to the FF-based hybrid plan technique the FFF mode allows further reduction of the average LAD dose for comparable target volume coverage without adverse low-dose exposure of contralateral structures. The combination of hybrid plan technique and 6 MV photon radiation in the FFF mode is suitable for use with hypofractionated dose schemes. The increased dose rate allows a substantial reduction of treatment time and thus beneficial application of the deep inspiration breath hold technique.

Entities:  

Keywords:  Breast cancer; Dose hypofractionation; Heart dose; Intensity-modulated radiotherapy; Volumetric-modulated arc therapy

Mesh:

Year:  2016        PMID: 26972086     DOI: 10.1007/s00066-016-0960-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  25 in total

1.  Flattening filter free vs flattened beams for breast irradiation.

Authors:  Kees H Spruijt; Max Dahele; Johan P Cuijpers; Marloes Jeulink; Derek Rietveld; Ben J Slotman; Wilko F A R Verbakel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-05       Impact factor: 7.038

2.  Octavius 4D characterization for flattened and flattening filter free rotational deliveries.

Authors:  Conor K McGarry; Barry F O'Connell; Mark W D Grattan; Christina E Agnew; Denise M Irvine; Alan R Hounsell
Journal:  Med Phys       Date:  2013-09       Impact factor: 4.071

3.  Deep inspiration breath hold technique reduces heart dose from radiotherapy for left-sided breast cancer.

Authors:  Amy J Hayden; Melissa Rains; Kenneth Tiver
Journal:  J Med Imaging Radiat Oncol       Date:  2012-08       Impact factor: 1.735

4.  Lowering whole-body radiation doses in pediatric intensity-modulated radiotherapy through the use of unflattened photon beams.

Authors:  Jason Cashmore; Mark Ramtohul; Dan Ford
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-16       Impact factor: 7.038

5.  Heart dose reduction in breast cancer treatment with simultaneous integrated boost: Comparison of treatment planning and dosimetry for a novel hybrid technique and 3D-CRT.

Authors:  Vincent Jöst; Matthias Kretschmer; Marcello Sabatino; Florian Würschmidt; Jörg Dahle; Friedrich Ueberle; Jörn Lorenzen
Journal:  Strahlenther Onkol       Date:  2015-07-24       Impact factor: 3.621

6.  Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy.

Authors:  David Palma; Emily Vollans; Kerry James; Sandy Nakano; Vitali Moiseenko; Richard Shaffer; Michael McKenzie; James Morris; Karl Otto
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

7.  Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01).

Authors:  Kathrin Dellas; Reinhard Vonthein; Jörg Zimmer; Stefan Dinges; Alexander D Boicev; Peter Andreas; Dorothea Fischer; Cornelia Winkler; Andreas Ziegler; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2014-04-16       Impact factor: 3.621

8.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Authors:  Joanne S Haviland; J Roger Owen; John A Dewar; Rajiv K Agrawal; Jane Barrett; Peter J Barrett-Lee; H Jane Dobbs; Penelope Hopwood; Pat A Lawton; Brian J Magee; Judith Mills; Sandra Simmons; Mark A Sydenham; Karen Venables; Judith M Bliss; John R Yarnold
Journal:  Lancet Oncol       Date:  2013-09-19       Impact factor: 41.316

9.  IMRT sparing of normal tissues in locoregional treatment of breast cancer.

Authors:  Jean-Michel Caudrelier; Joanne Meng; Bernd Esche; Laval Grimard; Terrence Ruddy; Kayvan Amjadi
Journal:  Radiat Oncol       Date:  2014-07-22       Impact factor: 3.481

Review 10.  The cardiac dose-sparing benefits of deep inspiration breath-hold in left breast irradiation: a systematic review.

Authors:  Lloyd M Smyth; Kellie A Knight; Yolanda K Aarons; Jason Wasiak
Journal:  J Med Radiat Sci       Date:  2015-01-07
View more
  7 in total

1.  Three-dimensional conformal versus intensity modulated radiotherapy in breast cancer treatment: is necessary a medical reversal?

Authors:  Alba Fiorentino; Ruggero Ruggieri; Niccolò Giaj-Levra; Gianluisa Sicignano; Gioacchino Di Paola; Stefania Naccarato; Sergio Fersino; Rosario Mazzola; Umberto Tebano; Francesco Ricchetti; Filippo Alongi
Journal:  Radiol Med       Date:  2016-10-24       Impact factor: 3.469

2.  Cardiac dose-sparing effects of deep-inspiration breath-hold in left breast irradiation : Is IMRT more beneficial than VMAT?

Authors:  Mazen Sakka; Leonie Kunzelmann; Martin Metzger; Gerhard G Grabenbauer
Journal:  Strahlenther Onkol       Date:  2017-06-23       Impact factor: 3.621

3.  Automated hybrid volumetric modulated arc therapy (HVMAT) for whole-breast irradiation with simultaneous integrated boost to lumpectomy area : A treatment planning study.

Authors:  Savino Cilla; Carmela Romano; Gabriella Macchia; Mariangela Boccardi; Livia P De Vivo; Vittoria E Morabito; Milly Buwenge; Lidia Strigari; Luca Indovina; Vincenzo Valentini; Francesco Deodato; Alessio G Morganti
Journal:  Strahlenther Onkol       Date:  2021-11-12       Impact factor: 3.621

4.  Hybrid planning techniques for hypofractionated whole-breast irradiation using flattening filter-free beams.

Authors:  Karunakaran Balaji; Sitaraman Balaji Subramanian; Krishnamoorthi Sathiya; Moorthi Thirunavukarasu; Chandrasekaran Anu Radha; Velayudham Ramasubramanian
Journal:  Strahlenther Onkol       Date:  2019-12-20       Impact factor: 3.621

Review 5.  Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer.

Authors:  Luca Cozzi; Frank Lohr; Antonella Fogliata; Davide Franceschini; Fiorenza De Rose; A R Filippi; Gabriele Guidi; Valentina Vanoni; Marta Scorsetti
Journal:  Radiat Oncol       Date:  2017-12-19       Impact factor: 3.481

6.  Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy : Results of a single, institutional, retrospective study.

Authors:  Volker Rudat; Alaa Nour; Mohamed Hammoud; Salam Abou Ghaida
Journal:  Strahlenther Onkol       Date:  2017-02-23       Impact factor: 3.621

7.  Hypofractionated Hybrid Radiotherapy Techniques for Synchronous Bilateral Breast Cancer.

Authors:  Karunakaran Balaji; Velayudham Ramasubramanian
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.